Health Economics Expertise

Evidence-based economic analysis to inform healthcare resource allocation and policy decisions

Our Health Economics Services

We provide comprehensive health economics expertise to support decision-making across pharmaceutical development, public health programs, and health system planning. Our rigorous analytical approaches combine economic theory, clinical evidence, and real-world data to generate actionable insights.

Core Health Economics Services

Comprehensive analytical approaches for healthcare decision-making

01

Cost-Effectiveness Analysis

Comprehensive evaluation of the cost-effectiveness of healthcare interventions using decision-analytic modeling, systematic literature reviews, and real-world data. We follow international guidelines to ensure credibility and acceptance.

  • Decision tree and Markov models
  • Probabilistic sensitivity analysis
  • Budget impact assessment
  • Value of information analysis
02

Budget Impact Analysis

Estimation of the financial consequences of adopting new healthcare technologies or programs. We develop transparent models that account for current practice patterns, market dynamics, and implementation timelines.

  • Multi-year financial projections
  • Scenario and sensitivity analyses
  • Resource utilization forecasting
  • Affordability assessments
03

Economic Burden Studies

Quantification of the economic impact of diseases and health conditions on patients, healthcare systems, and society. Our studies provide compelling evidence for prioritization and resource allocation decisions.

  • Direct medical cost analysis
  • Indirect cost estimation (productivity)
  • Intangible cost assessment
  • Comparative burden analysis
04

Health Technology Assessment

Systematic evaluation of the clinical, economic, social, and ethical implications of health technologies. We support HTA submissions to regulatory and reimbursement agencies worldwide.

  • Comprehensive dossier development
  • Evidence synthesis and review
  • Economic model adaptation
  • Response to agency questions
05

Economic Modeling

Development of sophisticated decision-analytic and epidemiological models to project long-term outcomes and costs. We create transparent, validated models that stand up to scientific scrutiny.

  • Cohort and individual-level simulation
  • Dynamic transmission modeling
  • Model validation and calibration
  • Open-source model development
06

Value-Based Pricing

Strategic pricing analysis based on clinical value, economic evidence, and market dynamics. We help manufacturers develop pricing strategies that reflect the value of their innovations.

  • Value story development
  • Price-volume optimization
  • Reimbursement strategy
  • Access landscape analysis

Methodological Excellence

Our approach is grounded in best practices and international standards

Guideline Adherence

We follow established guidelines from NICE, CADTH, ISPOR, and other leading agencies to ensure our analyses meet international standards for health economic evaluation

Transparency

All models and analyses are fully documented with clear assumptions, data sources, and computational methods to ensure reproducibility and facilitate review

Validation

Rigorous internal and external validation processes ensure model credibility. We conduct face validity checks, verification testing, and cross-validation against independent data

Uncertainty Analysis

Comprehensive sensitivity analyses to characterize parameter and structural uncertainty. We employ deterministic, probabilistic, and scenario-based approaches

Representative Case Studies

Examples of our health economics work across diverse contexts

Pharmaceutical

Novel Cancer Treatment

Cost-effectiveness analysis of a breakthrough oncology therapy for regulatory submission in five countries. Developed country-specific models incorporating local treatment patterns, costs, and willingness-to-pay thresholds.

Outcome: Successful reimbursement approvals in all target markets
Public Health

Vaccination Program

Economic evaluation of a national immunization program including budget impact analysis, cost-effectiveness modeling, and distributional analysis across population subgroups to inform policy decisions.

Outcome: Program expansion to additional age groups and higher-risk populations
Health Systems

Integrated Care Model

Comprehensive economic assessment of an integrated care delivery model including implementation costs, downstream healthcare utilization impacts, and productivity effects over a ten-year time horizon.

Outcome: Demonstrated cost savings and improved health outcomes supporting scale-up

Analytical Capabilities

Technical expertise and tools that support our health economics work

Statistical Analysis

Advanced statistical methods including regression modeling, survival analysis, and machine learning techniques. Proficiency in R, Stata, SAS, and Python.

Economic Modeling

Decision-analytic models, discrete event simulation, and agent-based modeling. Experience with TreeAge, R, Excel, and custom-built platforms.

Data Sources

Access to and experience with clinical trial data, real-world evidence, administrative claims, electronic health records, and patient-reported outcomes.

Evidence Synthesis

Systematic literature reviews, network meta-analysis, and matching-adjusted indirect comparisons following PRISMA and related guidelines.

Health Economics Portfolio

Our health economics work spans therapeutic areas, geographies, and stakeholder types. We have supported decision-making for pharmaceutical companies, government agencies, payers, providers, and international organizations across diverse health systems and resource settings.

0
Economic Evaluations Completed
0
Countries Covered
0
Therapeutic Areas

Need Health Economics Expertise?

Contact us to discuss how our services can support your project and decision-making needs